INTERNATIONAL PATENT: CRISTALFARMA S.R.L. FILES APPLICATION FOR "ORAL COMPOSITION COMPRISING EXTRACTS OF MUSA PARADISIACA AND ZINGIBER OFFICINALIS FOR USE IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX"

GENEVA, Sept. 16 -- CRISTALFARMA S.R.L. (Via San Giuseppe Cottolengo 1520143 Milano) filed a patent application (PCT/IB2025/051778) for "ORAL COMPOSITION COMPRISING EXTRACTS OF MUSA PARADISIACA AND ZINGIBER OFFICINALIS FOR USE IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX" on Feb 19, 2025. With publication no. WO/2025/186655, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEL BONO, Maria Cristina (c/o Cristalfarma S.r.l.Via San Giuseppe Cottolengo 1520143 Milano), BONOMO, Francesco (c/o Cristalfarma S.r.l.Via San Giuseppe ...